Status:
COMPLETED
Retrospective Transverse Observational Study Of Previous Study (Initial Protocol, B1811030)
Lead Sponsor:
Pfizer
Conditions:
Survival Status at Day 30 After the Last Intake
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this retrospective observational study is to collect only status survival data 30 days after the last dose of treatment of patients included in the initial protocol WYETH 3074A1-4448 / B18...
Eligibility Criteria
Inclusion
- All patients included in the previous study WYETH 3074A1-4448 then Pfizer B1811030 for which mortality status was not known at the closure of this previous study
Exclusion
- Patients who has withdrawn their consent for the study WYETH3074A1-4448 then Pfizer B1811030.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT01840319
Start Date
February 1 2013
End Date
July 1 2013
Last Update
July 28 2014
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Amiens, France, France, 80054
2
Pfizer Investigational Site
Marseille, France, France, 13385
3
Pfizer Investigational Site
Marseille, France, France, 13915
4
Pfizer Investigational Site
Montpellier, France, France, 34295